187 related articles for article (PubMed ID: 12384163)
1. Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer.
Veltri RW; Miller MC; O'dowd GJ; Partin AW
Urology; 2002 Oct; 60(4 Suppl 1):47-52. PubMed ID: 12384163
[TBL] [Abstract][Full Text] [Related]
2. Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: impact of changing disease demographics.
Miller MC; O'Dowd GJ; Partin AW; Veltri RW
Urology; 2001 Jun; 57(6):1105-11. PubMed ID: 11377319
[TBL] [Abstract][Full Text] [Related]
3. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Horninger W; Cheli CD; Babaian RJ; Fritsche HA; Lepor H; Taneja SS; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Bartsch G
Urology; 2002 Oct; 60(4 Suppl 1):31-5. PubMed ID: 12384160
[TBL] [Abstract][Full Text] [Related]
4. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
Partin AW; Brawer MK; Bartsch G; Horninger W; Taneja SS; Lepor H; Babaian R; Childs SJ; Stamey T; Fritsche HA; Sokoll L; Chan DW; Thiel RP; Cheli CD
J Urol; 2003 Nov; 170(5):1787-91. PubMed ID: 14532777
[TBL] [Abstract][Full Text] [Related]
5. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
6. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB
Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164
[TBL] [Abstract][Full Text] [Related]
7. Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.
Parsons JK; Brawer MK; Cheli CD; Partin AW; Djavan R
BJU Int; 2004 Jul; 94(1):47-50. PubMed ID: 15217429
[TBL] [Abstract][Full Text] [Related]
8. Can complexed prostate specific antigen enhance prostate cancer detection in Japanese men?
Okihara K; Ukimura O; Nakamura T; Mizutani Y; Kawauchi A; Naya Y; Uchida M; Ogiwara T; Miki T
Eur Urol; 2004 Jul; 46(1):57-64. PubMed ID: 15183548
[TBL] [Abstract][Full Text] [Related]
9. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
[TBL] [Abstract][Full Text] [Related]
10. Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Naya Y; Stamey TA; Cheli CD; Partin AW; Sokoll LJ; Chan DW; Brawer MK; Taneja SS; Lepor H; Bartsch G; Childs S; Fritsche HA; Babaian RJ
Urology; 2002 Oct; 60(4 Suppl 1):36-41. PubMed ID: 12384161
[TBL] [Abstract][Full Text] [Related]
11. Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial.
Okihara K; Ukimura O; Nakamura T; Ushijima S; Mizutani Y; Kawauchi A; Naya Y; Kojima M; Miki T
Urology; 2006 Feb; 67(2):328-32. PubMed ID: 16461082
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
Okegawa T; Noda H; Nutahara K; Higashihara E
Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.
Okegawa T; Noda H; Nutahara K; Higashihara E
Urology; 2000 May; 55(5):700-4. PubMed ID: 10792084
[TBL] [Abstract][Full Text] [Related]
14. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy.
Bratslavsky G; Fisher HA; Kaufman RP; Voskoboynik D; Nazeer T; Mian BM
Urol Oncol; 2008; 26(2):166-70. PubMed ID: 18312936
[TBL] [Abstract][Full Text] [Related]
15. Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL.
Berger AP; Cheli C; Levine R; Klocker H; Bartsch G; Horninger W
Urology; 2003 Nov; 62(5):840-4. PubMed ID: 14624905
[TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening.
Ellison L; Cheli CD; Bright S; Veltri RW; Partin AW
Urology; 2002 Oct; 60(4 Suppl 1):42-6. PubMed ID: 12384162
[TBL] [Abstract][Full Text] [Related]
17. Prediction of prostate cancer in extended-field biopsies of the prostate.
Winkler MH; Kulinskaya E; Gillatt DA
BJU Int; 2004 Mar; 93(4):516-21. PubMed ID: 15008721
[TBL] [Abstract][Full Text] [Related]
18. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Roddam AW; Duffy MJ; Hamdy FC; Ward AM; Patnick J; Price CP; Rimmer J; Sturgeon C; White P; Allen NE;
Eur Urol; 2005 Sep; 48(3):386-99; discussion 398-9. PubMed ID: 15982797
[TBL] [Abstract][Full Text] [Related]
19. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
[TBL] [Abstract][Full Text] [Related]
20. Complexed PSA performance for prostate cancer detection in an African-American population.
Martin B; Cheli CD; Lifsey D; Ward M; Pollard S; Jefferson L; Thiel RP; Rayford W
Urology; 2003 Nov; 62(5):835-9. PubMed ID: 14624904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
